Neurodegenerative Diseases

Our goal is to make Alzheimer's dementia preventable by 2025. We will do so with a primary focus in disease modification in Alzheimer's Disease, by selecting therapeutic targets with compelling evidence from human genetics and pathophysiology and using biomarkers to detect pathology and begin treatment earlier in the disease process where there is the greatest opportunity to prevent loss of function. We will complement our disease modification efforts through targeted pursuit of transformative therapies for cognitive / psychiatric symptoms.

There are no compounds available at this time